Skip to main content

Medical Marijuana

2010: The Year Dispensaries Died?

 

 

 

Do you want to see dispensaries die in Colorado?  If not, please DONATE TODAY. 

Since 2005, Sensible Colorado has been the leading voice for safe access to medical marijuana in this state.  Without our lawsuits and advocacy campaigns, dispensaries would not exist in Colorado-- and patients would be forced to go to alleys to get their medicine.  

2010 may be our toughest fight yet.  Law enforcement is planning to run a statewide bill to SHUT DOWN DISPENSARIES.  Please give whatever you can to help us fight this bill and secure safe access once and for all. 

To ensure a lasting contribution, become a MONTHLY DONOR today. Your support will help us continue the fight in 2010 and beyond.  Donations are fully tax-deductible.  Join the fight today!

Sensible Colorado: Exciting Speakers Announced for Saturday!


Stellar Speakers Announced for this Saturday's Stakeholder Meeting

Sensible Colorado is happy to announce the following line-up of speakers for 12/19's Medical Marijuana Stakeholder's Meeting.  

**Please arrive early and consider carpooling, as parking will be in high demand.**

1pm:  "Patients Perspective" panel featuring Damien LaGoy (AIDS activist), Dan Pope (Sensible Colorado), Roger Ronnas (Colorado Springs), and Vicki Meadows (Longmont).

2pm:  "Policy Makers" panel featuring Sen. Pat Steadman, fmr. Senator Bob Hagedorn, Sen. Chris Romer (invited), and Steve Fox (MPP.org).

3pm:  "Safe Access: Distribution Models" featuring Wanda James (Denver), Dr. Paul Bregman, Jill LaMouriex, and Todd Young (Boulder).

Sensible Colorado would like to send a warm thank you to the nascent DU Law Norml chapter for hosting this important event.  For more on this fien group, contact [email protected].

Event Details

WHAT:     Stakeholder Meeting to discuss medical marijuana policy in 2010

WHEN:     Saturday, December 19, 2009 from 1-4pm

WHERE:   University of Denver Law School, Student Forum, 2255 East Evans Ave., Denver CO 80208.  Map HERE.

WHO:       This event is free and open to the public.  Join patients, providers, legislators, and advocates.

Finally, please consider attending Arapahoe District Court this Friday (12/18) to show support for ending the city of Centennial's ban on dispensaries.  This hearing will occur at 1:30pm in courtroom 405 at 7325 S. Potomac St., Centennial, CO.

Americans for Safe Access: December Activist Newsletter

 

In This Issue:

AMA Says Marijuana is Medicine, Urges Change in Federal Position

ASA Threatens Suit if LA Bans Medical Marijuana Sales

ASA Targets Recalcitrant Law Enforcement Group

Celebrate the Year's Victories with ASA

ACTION ALERT: Urge Your Representative to cosponsor Truth in Trials!

Become an ASA Member!

Please support the work of Americans for Safe Access

On The Web:

ASA's Mission

What We Do

ASA Forums

ASA Blog

ASA YouTube

Legal Info

Take Action

Condition-Based Booklets

Join ASA Email Lists

ASA's Online Store

"Gear up" for medical cannabis activism with ASA's new T-shirts, hats, stickers, bags and more! All proceeds go to ASA advocacy

Americans for Safe Access

1322 Webster St., Ste. 402
Oakland, CA 94612
Phone: 510-251-1856
Fax: 510-251-2036

Email us!

Americans for Safe Access
Monthly Activist Newsletter

December 2009

Volume 4, Issue 12


AMA Says Marijuana is Medicine, Urges Change in Federal Position

Physicians' Group Wants Research Barriers Removed

The leading national doctors' group has now endorsed the medical use of cannabis and called for more research into the drug's potential. The move by the American Medical Association, the largest and most prestigious organization of physicians with nearly 250,000 members, officially calls on the federal government to recognize marijuana as a medicine and make it available for more clinical research.

The decision by the AMA marks a change in policy for the organization, which has historically supported the federal government's contention that there are no currently accepted medical uses for cannabis. Led by ASA Medical and Scientific Advisory Board member Dr. Sunil Aggrawal, the AMA's Medical Student Section pushed the larger organization to change its position based on the thousands of published, peer-reviewed scientific articles exploring the therapeutic applications of cannabis and cannabinoids, including 79 controlled clinical trials.

"It's been 72 years since the AMA has officially recognized that marijuana has both already-demonstrated and future-promising medical utility," said Dr. Aggarwal, who was one of the expert reviewers for the AMA. "The AMA has written an extensive, well-documented, evidence-based report."

The AMA's Council on Science and Public Health concluded that "controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis."

While these are conditions for which cannabis has been repeatedly shown to be effective, the AMA's formal recognition of the established science has larger policy implications. The U.S. federal government has long used the AMA's opposition to medical cannabis as justification for its own position. But that position has now been undermined by the AMA's report, which also urges the federal government to reconsider the classification of cannabis as a Schedule I drug. Reclassifying it as a medicine would, the AMA notes, help meet "the goal of facilitating clinical research and development of cannabinoid-based medicines, and alternate delivery methods."

The full report has not yet been made public, as the AMA hopes to publish it in a peer-reviewed journal "to help educate the medical community about the scientific basis of botanical cannabis-based medicines."
The report follows a resolution adopted in June by the Medical Student Section and responds to three resolutions dealing with medical marijuana that have come before the AMA in the past year. In February 2008, a position similar to the AMA's was adopted by the American College of Physicians, the country's second-largest physician group and the largest organization of doctors of internal medicine. That resolution also called on the federal government to review marijuana's status as a Schedule I controlled substance, meaning it is considered to be highly dangerous and have no medical use.

"The two largest physician groups in the U.S. have established medical marijuana as a health care issue that must be addressed," said ASA Government Affairs Director Caren Woodson. "Both organizations have underscored the need for change by placing patients above politics."

The AMA joins the American Nurses Association, the American Academy of Family Physicians, the British Medical Association, the Canadian Medical Association, and dozens of other organizations of health professionals in recognizing established therapeutic uses and calling for additional research.

See the AMA report at:
AmericansForSafeAccess.org/downloads/AMA_Report.pdf

Back to Top


Victory! Congress lifts ban on Washington, D.C.'s medical marijuana law

Dear friends:

The great news just keeps coming in.

Minutes ago, Congress voted to finally lift the 11-year ban on Washington, D.C.’s medical marijuana law.

The House voted 221-202 and the Senate voted 57-35 to approve the measure.

For the last 11 years, under a provision known as the Barr amendment, Congress has prevented Washington, D.C. from implementing the medical marijuana law passed by 69% of voters in 1998.

Repealing this amendment has been a primary focus of MPP's federal lobbying efforts for many years. In 2007, we even hired former Congressman Bob Barr (R-Ga.) — the original author of the amendment — to lobby to overturn it. And our lobbyists have worked directly with members of the House and Senate and their staff since 2006 to eliminate this democracy-unfriendly law.

In fact, senior appropriators in Congress sought out MPP staff to work through specifics and to help better understand D.C.'s medical marijuana law and the complicated legal maneuverings that led to the blocking of its implementation.  

MPP would like to thank Congressmen Jose Serrano (D-N.Y.), Dave Obey (D-Wis.), Speaker Nancy Pelosi (D-Calif.), and Senate Majority Whip Dick Durbin (D-Ill.) for their strong and abiding support of allowing D.C. to implement its medical marijuana law.

I also want to thank MPP's 29,000 dues-paying members, whose support helped to make this win possible. If you'd like to see more of these kinds of successes, I hope you'll donate to MPP's federal lobbying efforts. We're turning supporters' donations into results, and we can't do it without you.

Today's vote represents a victory not just for medical marijuana patients, but for all Americans, who have the right to determine their own policies without federal meddling. We'll be celebrating this victory in D.C. at our anniversary gala on January 13, and I hope you'll join us.

Sincerely,

null

Rob Kampia?
Executive Director?
Marijuana Policy Project?
Washington, D.C.

P.S. Time is running out on our matching campaign! A major philanthropist has committed to match the first $2.35 million that MPP can raise in 2009. Make twice the impact and donate today.

Congress Ends Ban on Medical Marijuana in Washington, D.C.

FOR IMMEDIATE RELEASE                                                                                                                                 

DECEMBER 13, 2009

Congress Ends Ban on Medical Marijuana in Washington, D.C.

Only Obama’s Signature Now Needed on Historic Measure

CONTACT: Aaron Houston, MPP director of government relations ……………………… 202-420-1031

WASHINGTON, D.C. — The U.S. Senate today passed historic legislation to end the decade long ban on implementation of the medical marijuana law Washington, D.C. voters passed in 1998.

            “This marks the first time in history that Congress has changed a marijuana law for the better,” said Aaron Houston, director of government relations for the Marijuana Policy Project in Washington, D.C.

            The “Barr amendment,” a rider attached to appropriations for the District, has forbidden D.C. from extending legal protection to qualified medical marijuana patients and has long been derided as an unconscionable intrusion by the federal government into the District's affairs. The omnibus spending bill, now approved by both chambers of Congress, removes this onerous provision, allowing the District to finally implement its voter-approved law. President Obama is expected to sign the bill shortly.

          “This is not only a huge victory for medical marijuana patients and for D.C. self-government, it marks a history-making shift on the medical marijuana issue," Houston said. “This is the first time Congress has ever given its assent to a state or local law that permits medical use of marijuana. It shows that Congress is listening to voters, who have supported protection for medical marijuana patients for well over a decade, as well as to the medical community’s growing recognition of marijuana’s medical value.

         “Coming on top of the announcement that the Department of Justice will not interfere with state medical marijuana laws, this shows that the ground has fundamentally shifted. It’s time for the federal government to take the logical next step as the American Medical Association just suggested, and reconsider marijuana’s classification as a Schedule I drug, which bars medical use.”

         Congressman Jose Serrano (D-N.Y.) originally removed the ban from the D.C. appropriations bill back in July after years of working to protect patients in Washington, D.C. Congressman David Obey (D-Wis.) helped ensure that the change made it through the legislative process and into the omnibus spending bill Congress passed today.

         Medical marijuana is legal under the laws of 13 states, with bills under consideration in several others, including New York, New Jersey, and Illinois.

         With more than 29,000 members and 100,000 e-mail subscribers nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. MPP believes that the best way to minimize the harm associated with marijuana is to regulate marijuana in a manner similar to alcohol. For more information, please visit http://MarijuanaPolicy.org.

####

The calls to Congress are working -- keep it up!

Friends:

The calls to Congress are working, and I've been getting great feedback from ASA activists.  Will you help?

Step by step, Congress is learning about the Truth in Trials Act. 

A good example is U.S. Representative Darrell Issa, who got a number of calls, emails, and letters from ASA activists in his Southern California district.   One such email came from ASA activist Joshua Lewis, who is Editor-in-Chief of the Medical Cannabis Journal. 

Congressman Issa sent the following response to Joshua:

-----
From: Congressman Darrell Issa
Sent: Thursday, December 03, 2009 10:29 AM
To: Joshua Lewis
Subject: Re: your recent message

Dear Mr. Lewis:

Thank you for taking the time to write to me to request my co sponsorship of the Truth in Trials Act

I have forwarded your letter to my Legislative Assistant who will investigate the possibility of cosponsoring this bill.

Thank you again for taking the time to bring your interest in this bill to my attention.

Sincerely,

Darrell Issa
Member of Congress
-----

Elected officials are starting to pay attention to what we are asking for.  Medical marijuana patients need protection from federal prosecution.  The Truth in Trials Act can help.

Will you call your Member of Congress?

Here's a reminder of the basic steps:

1. Find out who your Rep is.  Go to http://www.house.gov and type in your zip code in the upper left corner.  If it asks for your full "Zip+4", just look at your last piece of junk mail.

2. Dial 202-224-3121.  Ask the operator to transfer you to your Member of Congress.

3. Tell your Rep ... "I'm calling from ______ and I want you to cosponsor HR 3939, the Truth in Trials Act."

4. Reply to this email and tell me who you called.

Thanks!

- Sanjeev, ASA

ASA's 2009 Holiday Party -- Oakland, California

Americans for Safe Access 2009 Holiday Party

Wednesday, December 16th at 7:30 PM

Live Music with Brass Liberation Orchestra, DJs, Entertainment by Shamanic Cheerleaders, Silent Auction, Appetizers & Champagne.

Hosted by Steph Sherer, Executive Director & Founder of ASA
Screening of "Medical Cannabis in California: A report from the front-line"

Age 21+, Please Bring ID

Maxwell's Restaurant & Lounge
341 14th Street at Webster in Oakland

$25 Pre-sale tickets online:  www.americansforsafeaccess.org/holidayparty

Or call ASA's office at 510-251-1856

Press Release: Congress Close to Ending Ban on Medical Marijuana in Washington, D.C.

FOR IMMEDIATE RELEASE                                                                                              
DECEMBER 9, 2009

Congress Close to Ending Ban on Medical Marijuana in Washington, D.C.

CONTACT: Bruce Mirken, MPP director of communications …………… 415-585-6404 or 202-215-4205

WASHINGTON, D.C. — In a historic move, Congress is now poised to end the decade long ban on Washington, D.C. implementing the medical marijuana law District voters passed in 1998 with a 69 percent majority. Known as the Barr amendment, the provision – a rider attached to appropriations for the District -- has forbidden D.C. from extending legal protection to qualified medical marijuana patients and has been derided by advocates for years as an unconscionable intrusion by the federal government into the District's affairs.

            The omnibus spending bill that Democratic leaders will shortly be bringing to a vote in the House later this week removes this onerous provision. Once both chambers approve this final language and the president signs it, the Barr amendment will no longer block medical marijuana in D.C.

         "The end of the Barr amendment is now in sight,” said Aaron Houston, director of government relations for the Marijuana Policy Project in Washington. “This represents a huge victory not just for medical marijuana patients, but for all city residents who have every right to set their own policies in their own District without congressional meddling. D.C. residents overwhelmingly made the sensible, compassionate decision to pass a medical marijuana law, and now, more than 10 years later, suffering Washingtonians may finally be allowed to focus on treating their pain without fearing arrest."

            Advocates noted that the welcome repeal will come too late to help Jonathan Magbie, a D.C. quadriplegic man who died in prison in 2004 from lack of medical care after being convicted for using marijuana to treat his pain.

         "Jonathan Magbie would be alive today if the District been able to implement its medical marijuana law when it passed in 1998,” Houston said. "Perhaps now nobody in the District will ever have to suffer as he and his family did simply for using the medicine that works best for them."       

         Recently, the American Medical Association called on the federal government to reconsider marijuana’s classification as a Schedule I drug, which bars medical use.

         With more than 29,000 members and 100,000 e-mail subscribers nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. MPP believes that the best way to minimize the harm associated with marijuana is to regulate marijuana in a manner similar to alcohol. For more information, please visit http://MarijuanaPolicy.org.

####

Exciting times for medical marijuana in Rhode Island!

Dear friend, Since 2003, the Rhode Island Patient Advocacy Coalition (RIPAC) has led the Rhode Island’s medical marijuana movement. This past year has been monumental with the passage of the compassion center legislation which will allow three state-regulated, not-for-profit, retail dispensaries in RI. This victory will help to ensure that RI patients will have safe and affordable access to their medicine and make the RI Medical Marijuana Act the best in the country. Even before this success in June 2009, RI and RIPAC have been receiving amazing press coverage and recently we were even featured in The New York Times. We have been responding to the national medical marijuana developments with such actions as my interview on WPRI/Fox Providence and press statement in response to the Obama Administration’s announcement last month protecting patients in medical marijuana states. This is AMAZING progress and we need your continued support! http://ripatients.org/Donate/ RIPAC has expanded our services and we are now conducting orientations to provide patients and caregivers with the skills they need to make the most of the program. We continue to hold multiple meetings every month to educate patients, caregivers and community members. These meetings have gotten bigger and our monthly cardholder meetings now consistently include more than 10% of the state’s population of medical marijuana patients. None of this could have been possible without your continuous support. As a very small nonprofit, RIPAC relies heavily on private donors like you. With your generous support we can continue our work to advocate for patients, help educate them to navigate the program and help them retain a better quality of life. Your contribution, of any size, is crucial for us to continue our work to preserve the rights of patients. http://ripatients.org/Donate/ We are reaching much of the community, but now more than ever, we still have more work to do. We need to continue educating medical professionals and RIPAC, along with Patients Out of Time, is accomplishing this by hosting an international Continuing Medical Education “Clinical Conference on Cannabis” at the Crown Plaza Hotel in Warwick, RI from April 15-17, 2010. We also need to educate law enforcement personnel to protect our patients and we need to make sure that the compassion centers have the patients’ best interests in mind. In this season of giving, founding executive director Jesse Stout and I ask you to contribute $50, $100, $250 today with a check or credit card or become a member of our “Advocacy Circle” with monthly donations of $50, $40, $25 or whatever you can afford. Our goal is to raise $30,000! You can help with your gift, which is tax-deductible, and you can conveniently give by visiting our website and donating in the upper right hand corner. http://ripatients.org/Donate/ Happy Holiday Season to all! Sincerely, Stephen Hogan Jr. & Jesse Stout

Press Release: National Boards of Pharmacy Conference Focuses on Medical Marijuana

FOR IMMEDIATE RELEASE: December 3, 2009 CONTACT: ASA Media Liaison Kris Hermes at 510-681-6361 National Boards of Pharmacy Conference Focuses on Medical Marijuana Advocacy Group Presents on Medical Marijuana Alongside AMA & Other Health Experts Tucson, AZ -- As pharmacists and drug regulators from across the country convene in Tucson this week for their Winter symposium, they will be discussing medical marijuana, an issue which is headlining the agenda. The National Association of Boards of Pharmacy (NABP) opens its symposium on Thursday with several presentations on medical marijuana by an array of speakers and experts, including Caren Woodson, Government Affairs Director with Americans for Safe Access, the country's largest advocacy organization focused on the issue. "We welcome the interest in medical marijuana by the Boards of Pharmacy and want to work with them to address this public health issue," said Woodson. "State Boards of Pharmacy can have an impact on medical marijuana and we want to work with them to adopt sensible policies." The Oregon Board of Pharmacy has been ordered to remove marijuana from its state list of Schedule I drugs, per legislation signed by Governor Kulongoski in August. In addition, the Iowa Board of Pharmacy is currently considering rescheduling marijuana as a result of litigation. Woodson will co-present on a panel Thursday morning with Barry D. Dickinson, the Director of Science & Biotechnology for the American Medical Association, and Alice Mead, the Director of U.S. Public Relations for GW Pharmaceuticals, a U.K. company conducting clinical trials for a medical marijuana extract. The panel is entitled, "Should Marijuana be a Medical Option?" Later, Woodson will take part in a point-counterpoint on medical marijuana with Dickinson, Mead and other experts, including Andrea Barthwell, former deputy director for the U.S. Office of National Drug Control Policy and other marijuana researchers. The NABP symposium will be attended by Boards of Pharmacy executive officers, members, and other state and federal regulators as well as stakeholders in the pharmaceutical industry. Both the California Attorney General's office and the California Department of Public Health are sending representatives to the symposium. Attendees will be able to earn continuing pharmacy education credit for their participation in medical marijuana panels. The mission of the NABP is to assist its member boards in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health. The State Boards of Pharmacy oversee the classification of controlled substances, such as marijuana, at the state level, similar to the way that the Food & Drug Administration (FDA) and the Drug Enforcement Administration (DEA) oversee the federal classification of controlled substances. While state controlled substance lists routinely match the federal list, the State Boards of Pharmacy can change the classification of particular drugs independent of the federal government. The NABP symposium follows a report on medical marijuana issued last month by the American Medical Association, in which the oldest and largest physician-based group in the U.S. urged the federal government to review the Schedule I status for marijuana. The AMA noted that marijuana appeared to be efficacious for several health conditions and said that further research was needed to assess whether marijuana should continue to be considered a dangerous drug with no medical value. Further Information: The National Association of Boards of Pharmacy 2009 Symposium Schedule: http://www.nabp.net/whatsnew/meetings/2009symposium/ ASA National Policy Platform: http://www.safeaccessnow.org/downloads/ASA_Natl_Policy_Agenda_09-11.pdf # # #